Expansion in Demand for Thermometers
First written in FY2021-Q1. 5 of 11 entries say "Restated". Latest entry: FY2024-Q3.
The whole theme swung hardest in 2022: 1 of 9 companies on the "Worse" side.
4 other companies' latest entry also says "Restated".
- FY2024-Q3RestatedAnnual report
「The Health Care segment reported lower revenue, as weak thermometer demand continued and blood pressure monitors, although recovering, did not reach the previous year's level.」
Weak thermometer demand continued after the pandemic-related special demand, while blood pressure monitors showed signs of recovery but did not exceed the previous year's level, resulting in lower revenue for the Health Care segment. - FY2024-Q1RestatedAnnual report
「The Health Care segment reported lower revenue, as thermometer demand declined following the containment of COVID-19 and the number of blood pressure monitors sold decreased after price increases.」
The decline in thermometer demand as COVID-19 subsides and the decrease in sales volume following price increases for blood pressure monitors continue to weigh on revenue in the Health Care segment. - FY2023Declining thermometer demand as COVID-19 subsides; impact of blood pressure monitor price increasesAnnual report
「The Health Care segment reported lower revenue, as demand for thermometers declined in each market following the containment of COVID-19 and sales of blood pressure monitors declined after price increases were implemented.」
The drivers shifted from the special demand for thermometers through the previous fiscal year to a post-pandemic decline in demand and lower sales following price increases for blood pressure monitors. - FY2023-Q3Domestic thermometer sales firm; overseas sales weakAnnual report
「The Health Care segment reported lower revenue. Although thermometers and other products for the domestic market remained firm amid the renewed spread of COVID-19, overseas sales remained weak.」
While thermometers and other products for the domestic market remained firm against the backdrop of the renewed spread of COVID-19, overseas sales were weak, resulting in lower revenue for the Health Care segment. - FY2023-Q2Post-boom decline in thermometers; higher revenue from overseas sales and blood pressure monitorsAnnual report
「The Health Care segment reported higher revenue. Although thermometers experienced a post-boom reaction following the special demand created by the spread of COVID-19 in the previous fiscal year, overseas sales remained firm, while blood pressure monitors also performed steadily amid growing health awareness.」
While thermometers experienced a post-boom reaction following the special demand during the previous fiscal year's pandemic, overseas sales and blood pressure monitors remained steady, resulting in higher overall revenue for the Health Care segment. - FY2023-Q1Post-boom decline in thermometer demand; blood pressure monitors remain firmAnnual report
「The Health Care segment reported lower revenue. Blood pressure monitors remained firm amid growing health awareness, while thermometers declined sharply due to a post-boom reaction following the special demand created by the spread of COVID-19 in the previous fiscal year.」
Thermometer sales declined sharply due to a post-boom reaction following the special demand during the previous fiscal year's pandemic, while blood pressure monitors remained firm, resulting in lower overall revenue for the Health Care segment. - FY2022-Q3RestatedAnnual report
「Although the special demand for thermometers showed signs of easing, sales remained firm. Blood pressure monitors also performed well, supported by an increase in personal use amid growing health awareness, resulting in higher revenue for the Health Care segment.」
While the special demand for thermometers showed signs of easing, the increase in personal use of blood pressure monitors continued, resulting in higher overall revenue for the Health Care segment. - FY2022-Q2RestatedAnnual report
「Although the special demand for thermometers showed signs of easing, sales remained firm. Blood pressure monitors also performed well, supported by an increase in personal use amid growing health awareness, resulting in higher revenue for the Health Care segment.」
While the special demand for thermometers showed signs of easing, the increase in personal use of blood pressure monitors continued, resulting in higher overall revenue for the Health Care segment. - FY2022-Q1Thermometer demand boom eases; blood pressure monitor growthAnnual report
「Although the special demand for thermometers showed signs of easing, sales remained firm. Blood pressure monitors also performed well, supported by an increase in personal use amid growing health awareness, resulting in higher revenue for the Health Care segment.」
While thermometer demand showed signs of easing, personal use of blood pressure monitors increased, resulting in higher overall revenue for the Health Care segment. - FY2021-Q2RestatedAnnual report
「The Health Care segment reported higher revenue, primarily as a result of substantial growth in thermometer demand in the domestic market.」
Continued substantial growth in thermometer demand, mainly in the domestic market, contributed to higher revenue in the Health Care segment. - FY2021-Q1First statedAnnual report
「The Health Care segment reported higher revenue, primarily as a result of substantial growth in thermometer demand in the domestic market.」
Amid the spread of COVID-19, thermometer demand grew substantially, particularly in the domestic market, resulting in higher revenue for the Health Care segment.